These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10856553

  • 21. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
    Sato K, Yokota K, Matsui T, Imai K, Takishima T, Nakayama Y, Osakabe T, Yoshida M, Mieno H, Omiya H.
    Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440
    [No Abstract] [Full Text] [Related]

  • 22. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R, Bussenius-Kammerer M, Scholz D, Neuhaus R, Tolba RH, Fricke L, Müller V.
    Transplant Proc; 2001 Dec; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract] [Full Text] [Related]

  • 23. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract] [Full Text] [Related]

  • 24. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy.
    Crespo-Leiro MG, Paniagua MJ, Mosquera I, Tabuyo T, De la Fuente L, Bouzas B, Rodriguez JA, Hermida LF, Juffé A, Castro-Beiras A.
    Transplant Proc; 2002 Feb; 34(1):113-4. PubMed ID: 11959213
    [No Abstract] [Full Text] [Related]

  • 25. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 26. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C, Hollenbeck M, Ivens K, Heering P, Hetzel GR, Grabensee B.
    Transplant Proc; 2001 Aug; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract] [Full Text] [Related]

  • 27. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
    Fung JJ, Todo S, Tzakis A, Demetris A, Jain A, Abu-Elmaged K, Alessiani M, Starzl TE.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
    [No Abstract] [Full Text] [Related]

  • 28. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
    Kramer MR, Merin G, Rudis E, Bar I, Nesher T, Bublil M, Milgalter E.
    Transplant Proc; 1997 Sep; 29(6):2657-9. PubMed ID: 9290780
    [No Abstract] [Full Text] [Related]

  • 29. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J.
    Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279
    [Abstract] [Full Text] [Related]

  • 30. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
    Doria C, Jain AK, Scott VL, Gruttadauria S, Marino IR, Doyle HR, Fung JJ.
    Exp Clin Transplant; 2003 Jun 27; 1(1):48-55. PubMed ID: 15859907
    [Abstract] [Full Text] [Related]

  • 31. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience.
    Selzner N, Durand F, Bernuau J, Heneghan MA, Tuttle-Newhall JE, Belghiti J, Clavien PA.
    Transplantation; 2001 Sep 27; 72(6):1061-5. PubMed ID: 11579301
    [Abstract] [Full Text] [Related]

  • 32. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB.
    Transplant Proc; 1996 Apr 27; 28(2):974-6. PubMed ID: 8623484
    [Abstract] [Full Text] [Related]

  • 33. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
    Millis JM, Cronin DC, Newell KA, Bruce DS, Woodle ES, Grewal HP, Loss GE, Lissoos T, Conjeevaram H, Schiano T, O'Laughlin R, Charette J, McNaughton M, Baker AL, Thistlethwaite JR.
    Transplant Proc; 1998 Jun 27; 30(4):1407-8. PubMed ID: 9636569
    [No Abstract] [Full Text] [Related]

  • 34. Tacrolimus (FK 506) in kidney transplantation.
    Vanrenterghem Y.
    Transplant Proc; 1998 Aug 27; 30(5):2171-3. PubMed ID: 9723431
    [No Abstract] [Full Text] [Related]

  • 35. Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.
    Mazariegos GV, Salzedas AA, Jain A, Reyes J.
    Paediatr Drugs; 2001 Aug 27; 3(9):661-72. PubMed ID: 11688597
    [Abstract] [Full Text] [Related]

  • 36. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR, European Tacrolimus Renal Rejection Study Group.
    Transplant Proc; 2001 Aug 27; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract] [Full Text] [Related]

  • 37. Indications for mycofenolate mofetil therapy after liver transplantation.
    Platz KP, Mueller AR, Neuhaus P.
    Transplant Proc; 1997 Nov 27; 29(7):2880-1. PubMed ID: 9365601
    [No Abstract] [Full Text] [Related]

  • 38. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M, Banasik M, Patrzałek D, Klinger M.
    Ann Transplant; 2006 Nov 27; 11(2):51-6. PubMed ID: 17494290
    [Abstract] [Full Text] [Related]

  • 39. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M, Neumann U, Knoop M, Bechstein WO, Neuhaus P.
    Transplant Proc; 1998 Jun 27; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract] [Full Text] [Related]

  • 40. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM, Lilly LB, Marotta PJ, Mason AL, Bilodeau M, Vaillancourt M.
    Ann Hepatol; 2013 Jun 27; 12(2):282-93. PubMed ID: 23396740
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.